Dr. R.H.N. van Schaik

Update Persondata

• cancer
• cells
• disease
• dose
• drug
• gene
• genetics
• liver
• muscle
• patients
• receptor
• serum
• signaling
• survival

Active as

Publications

(the most recent at the top)

The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation

OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users

Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants

Covariates of tramadol disposition in the first months of life

Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: The Rotterdam study

All publications..

Current research

(the most recent research is at the top)
Project leader	Pharmacogenetics
Project leader	Predictive genetic determinants for paclitaxel and docetaxel therapy: a pharmacogenetic, pharmacokinetic and pharmacodynamic study

Completed research projects

(the most recent research is at the top)
Project leader	Molecular diagnosis of polymorphism of cytochrome P450 isoenzymes for optimalisation of chemotherapy in childhood cancer

Classification

D21300	Biochemistry